Time-course of arm lymphedema and potential risk factors for progression of lymphedema after breast conservation treatment for early stage breast cancer

Breast Journal

Volumn 18, Issue 3, 2012, Pages 219-225

  Bar Ad, Voichita ^a,b   Dutta, Pinaki R ^a,c   Solin, Lawrence J ^a,d   Hwang, Wei Ting ^a   Tan, Kay See ^a   Both, Stefan ^a   Cheville, Andrea ^a,e   Harris, Eleanor E R ^a,f  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d ALBERT EINSTEIN MEDICAL CENTER   (United States)

^e MAYO CLINIC   (United States)

^f H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

arm lymphedema progression; breast conservation treatment; early stage breast cancer; radiation treatment

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE;

ADULT; AGED; ARM; ARM LYMPHEDEMA; ARTICLE; BREAST CANCER; BREAST CONSERVATION TREATMENT; CANCER RADIOTHERAPY; CANCER STAGING; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FOLLOW UP; HUMAN; LYMPH NODE IRRADIATION; LYMPHEDEMA; MAJOR CLINICAL STUDY; PARTIAL MASTECTOMY; RISK FACTOR;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ARM; AXILLA; BREAST NEOPLASMS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPHEDEMA; MASTECTOMY, SEGMENTAL; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84861190861     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2012.01229.x     Document Type: Article

References (31)

1. Early Breast Cancer Trialists' Collaborative group. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival- an overview of the randomized trials. Lancet 2005; 366: 2087-106.
2. Sanghani M, Balk EM, Cady B,. Impact of axillary lymph node dissection on breast cancer outcome in clinically node negative patients: a systematic review and meta-analysis. Cancer 2009; 115: 1613-20.
3. Veronesi U, Paganelli G, Viale G, et al. Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomized controlled study. Lancet Oncol 2006; 7: 983-90. (Pubitemid 44804136)
4. Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 2006; 98: 599-609. (Pubitemid 43904843)
5. Wilke LG, McCall LM, Posther KE, et al. Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol 2006; 13: 491-500.
6. McLaughlin SA, Wright MJ, Morris KT, et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: patient perceptions and precautionary behaviors. J Clin Oncol 2008; 26: 5220-6.
7. Fleming ID, Cooper JS, Henson DE, et al. AJCC Cancer Staging Manual. (5th edn) Philadelphia, PA: Lippincott-Raven Publishers, 1997.
8. Greene FL, Page DL, Fleming ID, et al., American Joint Committee on Cancer AJCC Cancer Staging Manual. (6th edn) New York NY: Springer, 2002.
9. Santiago RJ, Wu L, Harris E, et al. Fifteen-year results of breast-conserving surgery and definitive irradiation for stage I and II breast cancer: the University of Pennsylvania experience. Int J Radiat Oncol Biol Phys 2004; 58: 233-40. (Pubitemid 38010357)
10. Bar Ad V, Cheville A, Solin LJ, Dutta P, Both S, Harris EER,. Time course of mild arm lympedema after breast conservation treatment for early-stage breast cancer. Int J Radiat Oncol Biol Phys 2010; 76: 85-90.
11. Ververs JM, Roumen RM, Vingerhoets AJ, et al. Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer. Eur J Cancer 2001; 37: 991-9. (Pubitemid 32397684)
12. Beaulac SM, McNair LA, Scott TE, et al. Lymphedema and quality of life in survivors of early-stage breast cancer. Arch Surg 2002; 137: 1253-7. (Pubitemid 35345897)
13. Soran A, D'Angelo G, Begovic M, et al. Breast cancer-related lymphedema. What are the significant predictors and how they affect the severity of lymphedema? Breast J 2006; 12: 536-43. (Pubitemid 44690842)
14. Van der Veen P, De Voogdt N, Lievens P, Duquet W, Lamote J, Sacre R,. Lymphedema development following breast cancer surgery with full axillary resection. Lymphology 2004; 37: 206-8. (Pubitemid 40082906)
15. Petrek JA, Senie RT, Peters M, Rosen PP,. Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer 2001; 92: 1368-77. (Pubitemid 32947819)
16. Johansson K, Ohlsson K, Ingvar C, Albertsson M, Ekdahl C,. Factors associated with the development of arm lymphedema following breast cancer treatment: a match pair case-control study. Lymphology 2002; 35: 59-71. (Pubitemid 34627661)
17. Erikson VS, Pearson ML, Ganz PA, Adams J, Kahn KL,. Arm edema in breast cancer patients. J Natl Cancer Inst 2001; 93: 96-111. (Pubitemid 32111987)
18. Roses DF, Brooks AD, Harris MN, Shapiro RL, Mitnick J,. Complications of level I and II axillary dissection in the treatment of carcinoma of the breast. Ann Surg 1999; 230: 194-201. (Pubitemid 30191885)
19. Kiel KD, Rademacker AW,. Early stage breast cancer: arm edema after wide excision and breast irradiation. Radiology 1996; 198: 279-83. (Pubitemid 26009708)
20. Werner RS, McCormick B, Petrek J, et al. Arm edema in conservatively managed breast cancer: obesity is a major predictive factor. Radiology 1991; 180: 177-84.
21. Hayes SB, Freedman GM, Li T, Anderson PR, Ross E,. Does axillary boost increase lymphedema compared with supraclavicular radiation alone after breast conservation? Int J Radiat Oncol Biol Phys 2008; 72: 1449-55.
22. Coen JJ, Taghian AG, Kachnic LA, Assaad SI, Powell SN,. Risk of lymphedema after regional nodal irradiation with breast conservation therapy. Int J Radiat Oncol Biol Phys 2003; 55: 1209-15. (Pubitemid 36338286)
23. Larson D, Weinstein M, Goldberg I, et al. Edema of the arm as a function of the extent of axillary surgery in patients with Stage I-II carcinoma of the breast treated with primary radiotherapy. Int J Radiat Oncol Biol Phys 1986; 12: 1575-82. (Pubitemid 17175241)
24. Norman SA, Localio AR, Kallan MJ, et al. Risk factors for lymphedema after breast cancer treatment. Cancer Epidemiol Biomarkers Prev 2010; 19: 2734-46.
25. Casley-Smith JR,. Alterations of untreated lymphedema and its grades over time. Lymphology 1995; 28: 174-85. (Pubitemid 26009460)
26. Koul R, Dufan T, Russell C, et al. Efficacy of complete decongestive therapy and manual lymphatic drainage on treatment-related lymphedema in breast cancer. Int J Radiat Oncol Biol Phys 2007; 67: 841-6. (Pubitemid 46223526)
27. Vignes S, Porcher R, Champagne A, Dupuy A,. Predictive factors of response to intensive decongestive physiotherapy in upper limb lymphedema after breast cancer treatment: a cohort study. Breast Cancer Res Treat 2006; 98: 1-6. (Pubitemid 44050775)
28. Ko DS, Lerner R, Klose G, Cosimi AB,. Effective treatment of lymphedema of the extremities. Arch Surg 1998; 133: 452-8. (Pubitemid 28193533)
29. Schmitz KH,. Balancing lymphedema risk: exercise versus deconditioning for breast cancer survivors. Exerc Sport Sci Rev 2010; 38: 17-24.
30. Schmitz KH, Ahmed RL, Troxel A, et al. Weight lifting in women with breast-cancer-related lymphedema. N Engl Med 2009; 361: 664-73.
31. Olszewski WL,. Contractility patterns of normal and pathologically changed human lymphatics. Ann N Y Acad Sci 2002; 979: 52-63. (Pubitemid 36121138)